ALLERGY
Some Selected Abstracts: | |
1. |
Aversano
M, Caiazzo P, Iorio G, Ponticiello L, Lagana B, Leccese F. Improvement
of chronic idiopathic urticaria with L-thyroxine: a new TSH role in
immune response?
Allergy. 2005 Apr;60(4):489-93. Endocrinology
Unit ASL NA3, Naples, Italy. BACKGROUND:
The association between chronic idiopathic urticaria (CIU) and
autoimmune thyroiditis (AT) is known, as well as major prevalence of
antithyroid antibodies in the allergical subjects and other autoimmune
diseases. We have evaluated the effects of l-thyroxine on clinical
symptoms of CIU in AT patients suggesting the hypothesis of a new
thyroid-stimulating hormone (TSH) role in immune system. METHODS: In 20
female patients with CIU + AT, both hypothyroid and euthyroid, we have
investigated the therapeutic effects of l-thyroxine dosed to suppress
the TSH. Free-T3, Free-T4, TSH, antithyroperoxidase and
antithyroglobulin antibodies, total immunoglobulin (Ig)E, Rheuma test
and eritro-sedimentation rate were monitored during treatment. Results:
In 16 patients a strong decrease of urticaria symptoms has happened
after 12 weeks. The TPO Ab and HTG Ab clearly decreased in 14 patients.
Furthermore, in two patients with rheumatoid arthritis and in two
patients with pollen allergy a strong decrease of rheuma test titer and
total IgE has happened. Conclusion: The reason of AT is associated to
CIU and others allergical and autoimmune diseases is poorly known. The
exclusive hormonal therapy reduces the symptoms of CIU and inflammatory
response in many chronic diseases associated to AT. We suggest a
stimulatory effect of TSH able to produce considerable changes of the
immune response and immune tolerance in patients with AT causing target
organs damage. The causal mechanism involves immune, nervous and
endocrine system, sharing a common set of hormones, cytokines and
receptors, in a unique totally integrated loop (the
neuro-immuno-endocrine axis). |
2. |
Bircher
AJ. Symptoms and danger signs in acute drug hypersensitivity.
Toxicology. 2005 Apr 15;209(2):201-7. Allergy
Unit, Department of Dermatology, University Hospital Basel, Petersgraben
4, CH-4031 Basel, Switzerland. andreas.bircher@unibas.ch Early
and rapid recognition of severe adverse drug reactions is essential.
Prompt withdrawal of the offending drug is the most important action to
minimize morbidity and mortality. Dependent on the type of reaction,
e.g. in immediate type reactions instant withdrawal and therapy are
mandatory, whereas in delayed reactions diagnosis as early as possible
may be life-saving. The skin is an important herald organ and may early
signal a severe evolution of a cutaneous reaction or involvement of
circulating blood cells or internal organs. A synthesis considering all
factors should be made to obtain an early and correct diagnosis. |
3. |
Bryant
R. Asthma in the pediatric sickle cell patient with acute chest
syndrome.
J Pediatr Health Care. 2005 May-Jun;19(3):157-62. Texas
Children's Hospital, Baylor College of Medicine, Houston, Texas, USA.
rxbryant@texaschildrenshospital.org INTRODUCTION: Acute chest syndrome (ACS) is a potential life-threatening complication of sickle cell disease (SCD). The purpose of this study was to identify the frequency of asthma in children with SCD who were diagnosed with ACS. The objective was to determine if an increased frequency of asthma exists in children with SCD and ACS. METHOD: A retrospective descriptive chart review covering the period from June 1997 to June 2002 was conducted on 60 children ranging in age from 1.5 years to 17 years who had SCD and ACS. Cross-tabs analysis and student t tests were used to determine the significance of the occurrence of asthma in children in whom ACS developed. RESULTS: Of the 60 eligible children with SCD, 53% (32/60) had asthma and/or abnormal pulmonary function tests prior to the development of ACS. DISCUSSION: This is the first study to report a slight increase in the frequency of asthma prior to the initial ACS in children with SCD. The small convenience sample size from one center may have been a limitation in this study to detect significant differences between the variables. |
4. |
Govindarajan
G, Bashir Q, Kuppuswamy S, Brooks C. Sweet syndrome associated with
furosemide.
South Med J. 2005 May;98(5):570-2. University
of Missouri Health Science Center, Department of Internal Medicine, MA
406, One Hospital Drive, Columbia, MO 65212, USA. govindarajang@health.missouri.edu This case report describes a case of Sweet syndrome (SS) related to use of furosemide in a 46-year-old female who was admitted for treatment of congestive heart failure. Three days after administration of furosemide, the patient had a fever and a skin eruption appeared on her wrists, forearms, and legs. Biopsy of the skin lesion was consistent with SS. Infection was thought to be unlikely because of negative blood cultures, echocardiography, and other imaging studies. Careful review of her medications revealed that the patient received furosemide before the appearance of the skin eruption and fever. After discontinuation of furosemide, the patient's skin lesion and fever resolved. A MEDLINE search from June 1966 to May 2004 revealed only one reference documenting the association of SS with furosemide administration. Patients who have development of SS without an obvious cause should have their medication list closely reviewed. |
5. |
Janse
AJ, Sinnema G, Uiterwaal CS, Kimpen JL, Gemke RJ. Quality of life
in chronic illness: perceptions of parents and paediatricians.
Arch Dis Child. 2005 May;90(5):486-91. Department
of Paediatrics, Wilhelmina Children's Hospital, University Medical
Centre Utrecht, Netherlands. AIMS:
To investigate the differences in perception of quality of life between
parents of chronically ill children and paediatricians at diagnosis and
follow up. Quality of life was assessed using the (HUI3). METHODS:
Longitudinal study (July 1999-January 2002) of 37 paediatricians and 181
parents of patients (children aged 1-17 years) with cystic fibrosis
admitted for a pneumonia or patients with newly diagnosed acute
lymphatic leukaemia, juvenile idiopathic arthritis, or asthma. Main
outcome measure was percentage agreement on the attributes of the HUI3
between parents and paediatricians. RESULTS: Differences in perception
of health and wellbeing between paediatricians and parents of children
with a chronic disease were found, not only at diagnosis but also after
a period of follow up. Differences were particularly clear in the
subjective attributes emotion (range of agreement 28-68%) and
pain/discomfort (range of agreement 11-33%). In all patient groups, at
baseline and follow up, the paediatrician assessed the patient to have
less pain/discomfort in comparison to the parents. Despite a prolonged
patient- paediatrician relationship, differences at follow up did not
decrease compared to baseline. CONCLUSION: At the onset of a chronic
disease, but also after a period of follow up, quality of life of
paediatric patients may be misunderstood by healthcare professionals,
especially in the subjective attributes. Systematic assessment of
quality of life may contribute to better understanding between
physicians and parents. |
6. |
Letko
E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens-Johnson
syndrome and toxic epidermal necrolysis: a review of the literature.
Ann Allergy Asthma Immunol. 2005 Apr;94(4):419-36; quiz 436-8, 456. Department
of Ophthalmology, Uveitis and Immunology Service, The Massachusetts Eye
and Ear Infirmary, Harvard Medical School, Boston, Massachusetts 02114,
USA. OBJECTIVE:
To perform a comprehensive review of Stevens-Johnson syndrome and toxic
epidermal necrolysis. DATA SOURCES: A MEDLINE search was performed for
the years 1975 to 2003 using the keywords Stevens-Johnson syndrome and
toxic epidermal necrolysis to identify relevant articles published in
English in peer-reviewed journals. STUDY SELECTION: All clinical studies
that reported on 4 or more patients, review articles, and experimental
studies that concerned disease mechanisms were selected and further
analyzed. Clinical reports that included fewer than 4 patients were
selected only if they were believed to carry a significant message about
disease mechanism or therapy. RESULTS: Stevens-Johnson syndrome and
toxic epidermal necrolysis seem to be variants of the same disease with
differing severities. A widely accepted consensus regarding diagnostic
criteria and therapy does not exist at present. Despite the recent
experimental studies, the pathogenic mechanisms of these diseases remain
unknown. Although progress in survival through early hospitalization in
specialized burn units has been made, the prevalence of life-long
disability from the ocular morbidity of Stevens-Johnson syndrome and
toxic epidermal necrolysis has remained unchanged for the past 35 years.
Further progress depends on modification of the acute phase of the
disease rather than continuation of supportive care. The available
published evidence indicates that a principal problem in the
pathogenesis is immunologic and that immunomodulatory intervention with
short-term, high-dose intravenous steroids or intravenous immunoglobulin
holds the most promise for effective change in survival and long-term
morbidity. CONCLUSIONS: The results of this review call for a widely
accepted consensus on diagnostic criteria for Stevens-Johnson and toxic
epidermal necrolysis and multicenter collaboration in experimental
studies and clinical trials that investigate disease mechanisms and
novel therapeutic interventions, respectively. |
7. |
Peacock
ME, Park DS, Swiec GD, Erley KJ. Perioral
angioedema associated with angiotensin-converting enzyme inhibitor.
J Periodontol. 2005 Apr;76(4):651-4. U.S.
Army, Landstuhl, Germany. mark.peacock@lnd.amedd.army.mil BACKGROUND:
Angioedema is a non-pruritic swelling usually limited to the skin and
mucous membranes of the face and perioral soft tissues. It can be life
threatening but usually is not, and can be managed with conservative
medical treatment unless the airway is endangered. Recent reports
suggest that angiotensin-converting enzyme (ACE) inhibitors can
predispose and/or precipitate angioedema, with a predilection toward
patients of African American ancestry. METHODS: This case report
involved a 65-year-old African American female who was being treated
surgically for localized chronic periodontitis. The procedure was
performed without incident, and the patient was alert and stable when
released. The next day, the patient called and reported that her lips
were swollen. She stated that this had happened a number of times over
the past several years, sometimes related to eating shellfish and other
times without any known precipitating factor. All previous episodes of
perioral swelling occurred after ACE inhibitor therapy had been
initiated. RESULTS: The patient was in no distress, with no other site
involvement. She was prescribed oral hydroxyzine and her appearance
returned to normal after 5 days. Although the patient had experienced
previous episodes of angioedema, none had been in response to any dental
procedure. She was referred to the Allergy and Immunology Clinic for
skin testing, the results of which were negative to shellfish with good
controls. Other potentiating etiologies were also ruled out by the
allergist. CONCLUSIONS: Angioedema is a recognized possible side effect
of ACE inhibitor therapy. The exact mechanism by which ACE inhibitors
induce angioedema is not known, although the risk of occurrence is much
greater in African Americans. Practitioners should be alert to this
potentially fatal condition in patients who take ACE inhibitors or the
newer angiotensin II receptor blockers (ARBs). |
8. |
Plotkin
SA. Vaccines: past, present and future. Nat Med. 2005 Apr;11(4 Suppl):S5-11. Sanofi Pasteur and the University of Pennsylvania, 4650 Wismer Road, Doylestown, Pennsylvania 18901, USA. Stanley.Plotkin@sanofipasteur.com The
vaccines developed over the first two hundred years since Jenner's
lifetime have accomplished striking reductions of infection and disease
wherever applied. Pasteur's early approaches to vaccine development,
attenuation and inactivation, are even now the two poles of vaccine
technology. Today, purification of microbial elements, genetic
engineering and improved knowledge of immune protection allow direct
creation of attenuated mutants, expression of vaccine proteins in live
vectors, purification and even synthesis of microbial antigens, and
induction of a variety of immune responses through manipulation of DNA,
RNA, proteins and polysaccharides. Both noninfectious and infectious
diseases are now within the realm of vaccinology. The profusion of new
vaccines enables new populations to be targeted for vaccination, and
requires the development of routes of administration additional to
injection. With all this come new problems in the production, regulation
and distribution of vaccines. |
9. |
Sabina
AB, Williams AL, Wall HK, Bansal S, Chupp G, Katz DL. Yoga
intervention for adults with mild-to-moderate asthma: a pilot study.
Ann Allergy Asthma Immunol. 2005 May;94(5):543-8. Yale-Griffin
Prevention Research Center, Derby, Connecticut 06418, USA. BACKGROUND:
Preliminary studies investigating yoga and breath work for treating
asthma have been promising. Several randomized controlled trials have
shown a benefit from yoga postures and breathing vs control, but the
control in these cases involved no intervention other than usual care.
This study advances the field by providing an active control. OBJECTIVE:
To determine the effectiveness and feasibility of a yoga and breath work
intervention for improving clinical indices and quality of life in
adults with mild-to-moderate asthma. METHODS: A randomized, controlled,
double-masked clinical trial was conducted between October 1, 2001, and
March 31, 2003. Random assignment was made to either a 4-week yoga
intervention that included postures and breath work or a stretching
control condition. Outcome measures were evaluated at 4, 8, 12, and 16
weeks and included the Mini Asthma Quality of Life Questionnaire, rescue
inhaler use, spirometry, symptom diaries, and health care utilization.
RESULTS: Sixty-two participants were randomized to the intervention and
control groups, and 45 completed the final follow-up measures.
Intention-to-treat analysis was performed. Significant within-group
differences in postbronchodilator forced expiratory volume in 1 second
and morning symptom scores were apparent in both groups at 4 and 16
weeks; however, no significant differences between groups were observed
on any outcome measures. CONCLUSIONS: Iyengar yoga conferred no
appreciable benefit in mild-to-moderate asthma. Circumstances under
which yoga is of benefit in asthma management, if any, remain to be
determined. |
Diagnosis, Diagnostics, Immunodiagnosis & Immunodiagnostics: |
12411.
Agterof MJ, Biesma DH. Images
in clinical Medicine. Bortezomib-induced skin lesions. N Engl J Med.
2005 Jun 16;352(24):2534. 12412.
Ahmed
T, Vaezi MF. The role of pH monitoring in extraesophageal
gastroesophageal reflux disease. Gastrointest Endosc Clin N Am. 2005
Apr;15(2):319-31. Review. 12413.
Alobid
I, Benitez P, Bernal-Sprekelsen M, Roca J, Alonso J, Picado C, Mullol J.
Nasal polyposis and its impact on quality of life: comparison between
the effects of medical and surgical treatments. Allergy. 2005
Apr;60(4):452-8. 12414.
American
Academy of Family Physicians. Information from your family doctor.
Treating my child's asthma. Am Fam Physician. 2005 May 15;71(10):1969. 12415.
Aversano
M, Caiazzo P, Iorio G, Ponticiello L, Lagana B, Leccese F. Improvement
of chronic idiopathic urticaria with L-thyroxine: a new TSH role in
immune response? Allergy. 2005 Apr;60(4):489-93.
12416.
Baydur
A. Not all that comes out
is hot air. Chest. 2005 May;127(5):1482-5. 12417.
Bergeron
C, Boulet LP, Hamid Q. Obesity, allergy and immunology. J Allergy Clin
Immunol. 2005 May;115(5):1102-4. Review. 12418.
Berkman
N, Avital A, Breuer R, Bardach E, Springer C, Godfrey S. Exhaled nitric
oxide in the diagnosis of asthma: comparison with bronchial provocation
tests. Thorax. 2005 May;60(5):383-8.
12419.
Beuther
DA, Sutherland ER. Obesity and pulmonary function testing. J Allergy
Clin Immunol. 2005 May;115(5):1100-1. 12420.
Bircher
AJ. Symptoms and danger signs in acute drug hypersensitivity.
Toxicology. 2005 Apr 15;209(2):201-7. Review. 12421.
Bischoff
S, Crowe SE. Gastrointestinal
food allergy: new insights into pathophysiology and clinical
perspectives. Gastroenterology. 2005 Apr;128(4):1089-113. Review. 12422.
Boushey
HA, Sorkness CA, King TS, Sullivan SD, Fahy JV, Lazarus SC, Chinchilli
VM, Craig TJ, Dimango EA, Deykin A, Fagan JK, Fish JE, Ford JG, Kraft M,
Lemanske RF Jr, Leone FT, Martin RJ, Mauger EA, Pesola GR, Peters SP,
Rollings NJ, Szefler SJ, Wechsler ME, Israel E; National Heart, Lung,
and Blood Institute's Asthma Clinical Research Network.
Daily versus as-needed corticosteroids for mild persistent
asthma. N Engl J Med. 2005 Apr 14;352(15):1519-28.
12423.
Bousquet
PJ, Co-Minh HB, Demoly P. Isolated urticaria to ondansetron and
successful treatment with granisetron. Allergy. 2005 Apr;60(4):543-4. 12424.
Brockow
K. Contrast media hypersensitivity--scope of the problem. Toxicology.
2005 Apr 15;209(2):189-92. Review. 12425.
Bruce
C, Thomas PS. The effect of marimastat, a metalloprotease inhibitor, on
allergen-induced asthmatic hyper-reactivity. Toxicol Appl Pharmacol.
2005 Jun 1;205(2):126-32. 12426.
Bryant
R. Asthma in the pediatric sickle cell patient with acute chest
syndrome. J Pediatr Health Care. 2005 May-Jun;19(3):157-62. 12427.
Chen
MJ, Wang TE, Chang WH, Tsai SJ, Liao WS. Endoscopic findings in a
patient with Henoch-Schonlein purpura. World J Gastroenterol. 2005 Apr
21;11(15):2354-6. 12428.
Chhabra
SK. Premenstrual asthma.
Indian J Chest Dis Allied Sci. 2005 Apr-Jun;47(2):109-16. Review. 12429.
Chhabra
SK. Guidelines for management of asthma: the gaps between theory and
practice. Indian J Chest Dis Allied Sci. 2005 Apr-Jun;47(2):77-80. 12430.
Chuchalin
A, Kasl M, Bengtsson T, Nihlen U, Rosenborg J. Formoterol used as needed
in patients with intermittent or mild persistent asthma. Respir Med.
2005 Apr;99(4):461-70. 12431.
Corry
DB. Resolving a case of split personality. Nat Immunol. 2005
May;6(5):432-4. 12432.
Courtney
AU, McCarter DF, Pollart SM. Childhood
asthma: treatment update. Am Fam Physician. 2005 May 15;71(10):1959-68.
Review. 12433.
Covar
RA, Cool C, Szefler SJ. Progression of asthma in childhood. J Allergy
Clin Immunol. 2005 Apr;115(4):700-7. 12434.
Demoly
P. Anaphylactic
reactions--value of skin and provocation tests. Toxicology. 2005 Apr
15;209(2):221-3. 12435.
Forastiere
F, Sunyer J, Farchi S, Corbo G, Pistelli R, Baldacci S, Simoni M,
Agabiti N, Perucci CA, Viegi G. Number of offspring and maternal
allergy. Allergy. 2005 Apr;60(4):510-4. 12436.
Freiman
A. Dermacase. Henoch-Schonlein purpura. Can Fam Physician. 2005
Apr;51:511-2. Review. 12437.
Gaston
B. Inhaled corticosteroid
dose reduction in childhood asthma: is nitrosopnea informative? Am J
Respir Crit Care Med. 2005 May 15;171(10):1065-6. 12438.
Govindarajan
G, Bashir Q, Kuppuswamy S, Brooks C. Sweet syndrome associated with
furosemide. South Med J. 2005 May;98(5):570-2. Review.
12439.
Harboe
T, Guttormsen AB, Irgens A, Dybendal T, Florvaag E. Anaphylaxis during
anesthesia in Norway: a 6-year single-center follow-up study.
Anesthesiology. 2005 May;102(5):897-903. 12440.
Hehn
J, Brocker EB, Goebeler M. Angioedema,
eosinophilia, and fever. Arch Dermatol. 2005 May;141(5):633-8. 12441.
High
WA, Hoang MP, Miller MD. Pruritic urticarial papules and plaques of
pregnancy with unusual and extensive palmoplantar involvement. Obstet
Gynecol. 2005 May;105(5 Pt 2):1261-4. 12442.
Hoffmann-Sommergruber
K; SAFE consortium. The SAFE project: 'plant food allergies: field to
table strategies for reducing their incidence in Europe' an EC-funded
study. Allergy. 2005 Apr;60(4):436-42. Review. 12443.
Holten
KB; American Academy of Dermatology. How should we care for atopic
dermatitis? J Fam Pract. 2005 May;54(5):426-7. 12444.
Janse
AJ, Sinnema G, Uiterwaal CS, Kimpen JL, Gemke RJ. Quality of life in
chronic illness: perceptions of parents and paediatricians. Arch Dis
Child. 2005 May;90(5):486-91. 12445.
Kaur
C, Bansal SK, Chhabra SK. Study on serum and urinary cortisol levels of
asthmatic patients after treatment with high dose inhaled beclomethasone
dipropionate or budesonide. Indian J Chest Dis Allied Sci. 2005
Apr-Jun;47(2):89-95. 12446.
Kimura
A, Yoshino H, Yuasa T. Chronic inflammatory demyelinating polyneuropathy
in a patient with hyperIgEaemia. J Neurol Sci. 2005 Apr
15;231(1-2):89-93. 12447.
Komericki
P, Fellner P, El-Shabrawi Y, Ardjomand N. Keratopathy after ultraviolet
B phototherapy. Wien Klin Wochenschr. 2005 Apr;117(7-8):300-2.
12448.
Korzenik
JR. Past and current theories of etiology of IBD: toothpaste, worms, and
refrigerators. J Clin Gastroenterol. 2005 Apr;39(4 Suppl 2):S59-65.
Review. 12449.
Laroche
D. Immediate reactions to contrast media: mediator release and value of
diagnostic testing. Toxicology. 2005 Apr 15;209(2):193-4. Review.
12450.
Letko
E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS.
Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the
literature. Ann Allergy Asthma Immunol. 2005 Apr;94(4):419-36; quiz
436-8, 456. Review. 12451.
Luskin
AT. What the asthma end points we know and love do and do not tell us. J
Allergy Clin Immunol. 2005 Apr;115(4 Suppl):S539-45. Review. 12452.
Malmberg
LP, Turpeinen H, Rytila P, Sarna S, Haahtela T. Determinants of
increased exhaled nitric oxide in patients with suspected asthma.
Allergy. 2005 Apr;60(4):464-8. 12453.
Mansur
AT, Aydingoz IA. A case of toxic epidermal necrolysis with lesions
mostly on sun-exposed skin. Photodermatol Photoimmunol Photomed. 2005
Apr;21(2):100-2. 12454.
Matsumoto
K, Shimanouchi Y, Kawakubo K, Oishi N, Wakiguchi H, Futamura K, Saito H.
Infantile eczema at one month of age is associated with cord
blood eosinophilia and subsequent development of atopic dermatitis and
wheezing illness until two years of age. Int Arch Allergy Immunol.
2005;137 Suppl 1:69-76. 12455.
Nel
A. Atmosphere. Air pollution-related illness: effects of particles.
Science. 2005 May 6;308(5723):804-6. 12456.
Nicholson
PJ, Cullinan P, Taylor AJ, Burge PS, Boyle C.
Evidence based guidelines for the prevention, identification, and
management of occupational asthma. Occup Environ Med. 2005
May;62(5):290-9. Review. 12457.
Nunnelee
JD. Summer injuries. Bites & stings. RN. 2005 Apr;68(4):56-8, 60-1;
quiz 62. Review. 12458.
Palomares
O, Cuesta-Herranz J, Rodriguez R, Villalba M. A recombinant precursor of
the mustard allergen Sin a 1 retains the biochemical and immunological
features of the heterodimeric native protein. Int Arch Allergy Immunol.
2005 May;137(1):18-26. 12459.
Radcliffe
M, Scadding G, Brown HM. Lupin flour anaphylaxis. Lancet. 2005 Apr
9-15;365(9467):1360. 12460.
Ritz
BW, Lord RS. Case study: The effectiveness of a dietary supplement
regimen in reducing IgG-mediated food sensitivity in ADHD. Altern Ther
Health Med. 2005 May-Jun;11(3):72-5. 12461.
Sabina
AB, Williams AL, Wall HK, Bansal S, Chupp G, Katz DL. Yoga intervention
for adults with mild-to-moderate asthma: a pilot study. Ann Allergy
Asthma Immunol. 2005 May;94(5):543-8. 12462.
Saeed
SA. Hyposensitization. J Coll Physicians Surg Pak. 2005 Apr;15(4):250. 12463.
Sahin
MT, Ozturkcan S, Inanir I, Filiz EE. Norfloxacin-induced toxic epidermal
necrolysis. Ann Pharmacother. 2005 Apr;39(4):768-70. 12464.
Shirai
T, Matsui T, Suzuki K, Chida K. Effect of pet removal on pet allergic
asthma. Chest. 2005 May;127(5):1565-71. 12465.
Shivbalan
S, Balasubramanian S, Anandnathan K. What do parents of asthmatic
children know about asthma?: An Indian perspective. Indian J Chest Dis
Allied Sci. 2005 Apr-Jun;47(2):81-7.
12466.
Song
TT, Nelson MR, Chang JH, Engler RJ, Chowdhury BA. Adequacy of the
epinephrine autoinjector needle length in delivering epinephrine to the
intramuscular tissues. Ann Allergy Asthma Immunol. 2005
May;94(5):539-42. 12467.
Sood
A. Does obesity weigh heavily on the health of the human airway? J
Allergy Clin Immunol. 2005 May;115(5):921-4. 12468.
Szefler
SJ. Airway remodeling: therapeutic target or not? Am J Respir Crit Care
Med. 2005 Apr 1;171(7):672-3. 12469.
Szefler
SJ. Facing the challenges of childhood asthma: what changes are
necessary? J Allergy Clin Immunol. 2005 Apr;115(4):685-8. Review. 12470.
Tamura
G, Suda Y. Images in clinical medicine. Airway dilatation after
inhalation of a beta-agonist. N Engl J Med. 2005 Apr 14;352(15):e14. 12471.
Tuchinda
C, Leenutaphong V, Sudtim S, Lim HW. Fixed solar urticaria induced by
UVA and visible light: a report of a case. Photodermatol Photoimmunol
Photomed. 2005 Apr;21(2):97-9. Review. 12472.
Varadarajulu
S. Urticaria and angioedema. Controlling acute episodes, coping with
chronic cases. Postgrad Med. 2005 May;117(5):25-31. Review. 12473.
Viljanen
M, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T,
Tuure T, Kuitunen M. Probiotics in the treatment of atopic
eczema/dermatitis syndrome in infants: a double-blind placebo-controlled
trial. Allergy. 2005 Apr;60(4):494-500. 12474.
Wang
J, Sicherer SH. Anaphylaxis following ingestion of candy fruit chews.
Ann Allergy Asthma Immunol. 2005 May;94(5):530-3. 12475.
Welt
K, Hinrichs R, Ott S, Thalmann M, Dieckmannken J, Schneider LA, Staib G,
Scharffetter-Kochanek K. Anaphylaxis after the ingestion of lamb meat.
Allergy. 2005 Apr;60(4):545. 12476.
Wilson
C. Recurrent vulvovaginitis candidiasis; an overview of traditional and
alternative therapies. Adv Nurse Pract. 2005 May;13(5):24-9; quiz 30.
Review. 12477.
Yawalkar
N. Drug-induced exanthems. Toxicology. 2005 Apr 15;209(2):131-4. Review.
|
Pathogenesis |
12478. Aster RH. Drug-induced immune cytopenias. Toxicology. 2005 Apr 15;209(2):149-53. 12479.
Berger
RE. Fixed drug eruption--a sexually inducible reaction? J Urol. 2005
Jun;173(6):1990. 12480.
Carraro
S, Corradi M, Zanconato S, Alinovi R, Pasquale MF, Zacchello F, Baraldi
E. Exhaled breath
condensate cysteinyl leukotrienes are increased in children with
exercise-induced bronchoconstriction. J Allergy Clin Immunol. 2005
Apr;115(4):764-70. 12481.
Cavani
A. Breaking tolerance to
nickel. Toxicology. 2005 Apr 15;209(2):119-21. Review. 12482.
Christiansen
C. X-ray contrast media--an
overview. Toxicology. 2005 Apr 15;209(2):185-7. Review. 12483.
Cloutier
MM, Hall CB, Wakefield DB, Bailit H. Use of asthma guidelines by primary
care providers to reduce hospitalizations and emergency department
visits in poor, minority, urban children. J Pediatr. 2005
May;146(5):591-7. 12484.
Currie
GP, Lee DK. Beneficial antiinflammatory effects of leukotriene receptor
antagonists in asthma. Chest. 2005 Apr;127(4):1458. 12485.
Falcone
FH, Pritchard DI. Parasite role reversal: worms on trial. Trends
Parasitol. 2005 Apr;21(4):157-60. Review. 12486.
Fineberg
SE, Kawabata T, Finco-Kent D, Liu C, Krasner A. Antibody response to
inhaled insulin in patients with type 1 or type 2 diabetes. An analysis
of initial phase II and III inhaled insulin (Exubera) trials and a
two-year extension trial. J Clin Endocrinol Metab. 2005
Jun;90(6):3287-94. 12487.
Gern
JE, Rosenthal LA, Sorkness RL, Lemanske RF Jr. Effects of viral
respiratory infections on lung development and childhood asthma. J
Allergy Clin Immunol. 2005 Apr;115(4):668-74; quiz 675. Review. 12488.
Greenberger
PA. Epinephrine for
anaphylaxis. Ann Allergy Asthma Immunol. 2005 May;94(5):515-6. 12489.
Jain
S. Proton-pump inhibitor therapy for gastroesophageal reflux disease:
does it treat the asthma? Chest. 2005 Apr;127(4):1097-8. 12490.
Kim
LS, Riedlinger JE, Baldwin CM, Hilli L, Khalsa SV, Messer SA, Waters RF.
Treatment of seasonal allergic rhinitis using homeopathic
preparation of common allergens in the southwest region of the US: a
randomized, controlled clinical trial. Ann Pharmacother. 2005
Apr;39(4):617-24. 12491.
Konno
S, Golden DB, Schroeder J, Hamilton RG, Lichtenstein LM, Huang SK.
Increased expression of osteopontin is associated with long-term
bee venom immunotherapy. J Allergy Clin Immunol. 2005 May;115(5):1063-7.
12492.
Kuehn
BM. Therapy takes wheeze out of cat allergies. JAMA. 2005 May
11;293(18):2201. 12493.
Li
YF, Langholz B, Salam MT, Gilliland FD. Maternal and grandmaternal
smoking patterns are associated with early childhood asthma. Chest. 2005
Apr;127(4):1232-41. 12494.
Linhart
B, Hartl A, Jahn-Schmid B, Verdino P, Keller W, Krauth MT, Valent P,
Horak F, Wiedermann U, Thalhamer J, Ebner C, Kraft D, Valenta R. A
hybrid molecule resembling the epitope spectrum of grass pollen for
allergy vaccination. J Allergy Clin Immunol. 2005 May;115(5):1010-6. 12495.
Linneberg
A. Hypothesis: urbanization and the allergy epidemic--a reverse case of
immunotherapy? Allergy. 2005 Apr;60(4):538-9. 12496.
Liu
XS, Xu YJ. Potassium channels in airway smooth muscle and airway
hyperreactivity in asthma. Chin Med J (Engl). 2005 Apr 5;118(7):574-80.
Review. 12497.
McBrien
ME, Webb ST, Breslin. Anaphylaxis and anaesthesia. Br J Anaesth. 2005
Apr;94(4):547-8; author reply 548. 12498.
McKeever
TM, Lewis SA, Smit HA, Burney P, Britton JR, Cassano PA.
The association of acetaminophen, aspirin, and ibuprofen with
respiratory disease and lung function. Am J Respir Crit Care Med. 2005
May 1;171(9):966-71. 12499.
Mertes
PM. Anaphylactic reactions during anaesthesia--let us treat the problem
rather than debating its existence. Acta Anaesthesiol Scand. 2005
Apr;49(4):431-3. 12500.
Murch
S. Diet, immunity, and autistic spectrum disorders. J Pediatr. 2005
May;146(5):582-4. Review. 12501.
Peacock
ME, Park DS, Swiec GD, Erley KJ. Perioral angioedema associated with
angiotensin-converting enzyme inhibitor. J Periodontol. 2005
Apr;76(4):651-4. 12502.
Prescott
RA, Potter PC. Hypersensitivity to airborne spitting cobra snake venom.
Ann Allergy Asthma Immunol. 2005 May;94(5):600-3. 12503.
Rahman
M, Haider N. Anticonvulsant hypersensitivity syndrome from addition of
lamotrigine to divalproex. Am J Psychiatry. 2005 May;162(5):1021. 12504.
Romano
A, Gueant-Rodriguez RM, Viola M, Gaeta F, Caruso C, Gueant JL.
Cross-reactivity among drugs: clinical problems. Toxicology. 2005 Apr
15;209(2):169-79. Review. 12505.
Shi
HZ. DNA vaccine and asthma therapy. Chin Med J (Engl). 2005 Apr
5;118(7):531-3. 12506.
Szeplaki
G, Varga L, Valentin S, Kleiber M, Karadi I, Romics L, Fust G, Farkas H.
Adverse effects of danazol prophylaxis on the lipid profiles of
patients with hereditary angioedema. J Allergy Clin Immunol. 2005
Apr;115(4):864-9. 12507.
Thomas
M, Crawford I. Best evidence topic report. Glucagon infusion in
refractory anaphylactic shock in patients on beta-blockers. Emerg Med J.
2005 Apr;22(4):272-3. Review. 12508.
Williams
HC. Clinical practice. Atopic dermatitis. N Engl J Med. 2005 Jun
2;352(22):2314-24. Review. |
Vaccines: |
12509. Plotkin SA. Vaccines: past, present and future. Nat Med. 2005 Apr;11(4 Suppl):S5-11 |
Therapy: |
12510.
Cace
N, Brusich S, Dessardo S, Ahel J. Cardiopulmonary bypass in a child with
hereditary angioedema. Pediatr Int. 2005 Apr;47(2):214-6. 12511.
Check
E. Gene therapists urged to learn more immunology. Nature. 2005 Apr
14;434(7035):812. 12512.
Green
R, Ball A. Alpha-agonists for the treatment of anaphylactic shock.
Anaesthesia. 2005 Jun;60(6):621-2. 12513.
Kemp
SF. Got epinephrine? Many patients with anaphylaxis reportedly stuck
with no epinephrine syringes. Ann Allergy Asthma Immunol. 2005
May;94(5):513-4. 12514.
Mennick
F. Treating asthma in pregnancy: what's good for women is good for
fetuses, too. Am J Nurs. 2005 Apr;105(4):20. 12515.
Muething
SE, Kotagal U. Reliability of the health care delivery system. J Pediatr.
2005 May;146(5):581-2. 12516.
Walters
JA, Wood-Baker R, Walters EH. Long-acting beta2-agonists in asthma: an
overview of Cochrane systematic reviews. Respir Med. 2005
Apr;99(4):384-95. Review. |